April 05, 2006
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
FDA grants approval for generic glaucoma drug
BUFFALO GROVE, Ill. — The Food and Drug Administration granted marketing approval to Akorn for its solution of brimonidine tartrate for the treatment of glaucoma. The active ingredient is also found in Allergan’s Alphagan line.
Akorn noted this is its first product approval since a manufacturing facility inspection in 2005 was successful.